Patient
SITE010-0221
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE010 (ESP) (Dr. Silva)
consented 2026-05-16
Adverse events
4
Serious AEs
0
Open data queries
1
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-01-31 (study day 65); relationship: not assessed
Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-01-22 (study day 56); relationship: not assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-03 (study day 37); relationship: NOT RELATED
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-11-29 (study day 2); relationship: NOT RELATED
Data queries 1
AE Anaemia (grade 1) for SITE010-0221 has onset 2026-06-05, 1 d before first dose on 2026-06-06. Confirm onset date or record as pre-treatment.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.